*Corresponding author:Husayn Ahmed P, National Centre for Biological Sciences, India
Received: November 16, 2018; Published: November 21, 2018
To view the Full Article Peer-reviewed Article PDF
Since the initial studies in the 1950s, the field of pharmacogenetics has shown a lot of promise. The advent of high-throughput technology and next-generation sequencing has only added to the development of this field. Amidst several challenges like the lack of a comprehensive genomic database and varied prescription practices, pharmacogenetics has immense potential from the personalized medicine, novel biomarker discovery and drug development perspective in a genetically diverse population like India.
Keywords : EMEA: European Agency For Evaluation of Medicinal Products, ADRS: Adverse Drug Reactions, PD: Pharmacodynamics, PK: Pharmacokinetics, CPIC: Clinical Pharmacogenetics Implementation ConsortiumIntroduction| Pharmacogenetics in a Nutshell and its History| Need for Pharmacogenetics in the Indian Context| Potential Applications and Challenges| Conclusion References|